Related Experiment Video

Updated: Sep 28, 2026

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

Chlamydia pneumoniae and cardiovascular disease

Mikkel M Larsen1, Birgitte Moern, Andrew Fuller

  • 1Research Unit Q, Department of Infectious Diseases, Aarhus University Hospital, Skejby Sygehus, Denmark. MLQ@sks.aaa.dk

The Medical Journal of Australia
|November 14, 2002
PubMed

Insights

Chlamydia pneumoniae infection is linked to cardiovascular disease risk, but a causal relationship remains unproven. Current evidence does not support antibiotic treatment for cardiovascular conditions.

Area of Science:

  • Infectious Disease Epidemiology
  • Cardiovascular Medicine
  • Microbiology

Background:

  • Chlamydia pneumoniae found in atherosclerotic plaques suggests a potential role in cardiovascular disease.
  • Seropositivity to C. pneumoniae correlates with a slightly elevated risk of coronary events.
  • Establishing a definitive etiological link is challenging due to the absence of a gold standard for diagnosing chronic vascular infections.

Purpose of the Study:

  • To review the current evidence on the association between Chlamydia pneumoniae and cardiovascular disease.
  • To evaluate the ambiguous outcomes of macrolide treatment and prevention trials for cardiovascular disease.
  • To discuss the implications for diagnosing and treating potential C. pneumoniae-related cardiovascular pathology.

Main Methods:

  • Review of case-control studies and prospective trials investigating Chlamydia pneumoniae and cardiovascular disease.
  • Analysis of macrolide treatment outcomes for cardiovascular disease prevention.
  • Assessment of diagnostic challenges for chronic vessel infection.

Main Results:

  • Ambiguous results from macrolide trials suggest a possible short-term preventive effect on cardiovascular events.
  • The precise mechanism of macrolides (antimicrobial vs. anti-inflammatory) in cardiovascular disease remains undetermined.
  • Ongoing larger, longer prospective trials are expected to clarify the association.

Conclusions:

  • No definitive etiological link between Chlamydia pneumoniae and cardiovascular disease has been established.
  • Current evidence does not support the routine use of antibiotics for treating cardiovascular disease.
  • Further research is needed to elucidate the role of C. pneumoniae in cardiovascular pathology.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following: